Share of Eli Lilly surged on their latest Q1 2024 earnings results. Damien Conover, director of healthcare equity research at Morningstar, joins BNN Bloomberg to explain why he still has a sell rating on the stock.
Her doctor suggested it might have been a problem with the medicine itself. “That’s not really something you want to hear,” Posey said. It’s nearly impossible to know who’s taking these drugs. Compounded medications are generally not paid for by insurance, putting them out of view of systems that normally track prescriptions. The FDA doesn’t monitor how many prescriptions are filled for compounded drugs and at least 20 state boards of pharmacy told Bloomberg they’re not keeping a record either.
Stephen Peacock, chief medical officer of Henry Meds, said patients might prefer their offerings because they’re afraid of needles. When asked what data Henry Meds has to show their dissolving drugs are as effective as the shots, he didn’t provide any. Discussing the caliber of the company’s products, he said “I’m very confident in the safety and efficacy of our medications.”
Compounders started to work on a bigger scale in the 1990s and early 2000s, raising concerns. But lawmakers’ attempts to reform the system were successfully fought by pharmacies, resulting in scatter-shot regulation. That came to a head in 2012, when at least 64 people died and over 700 got sick from contaminated compounded drugs made by one pharmacy.